Profile data is unavailable for this security.
About the company
Hyphens Pharma International Limited is a Singapore-based specialty pharmaceutical and consumer healthcare company. The Company's principal activities are those of an investment holding company and provision of management services. The Company's segments include Specialty pharma principals, Proprietary brands, and Medical hypermart and digital. The Specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The Proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The Medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position themselves as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.
- Revenue in SGD (TTM)170.60m
- Net income in SGD8.57m
- Incorporated2017
- Employees440.00
- LocationHyphens Pharma International Ltd16 Tai Seng Street, Level 4 534138SingaporeSGP
- Phone+65 62965751
- Fax+65 62931116
- Websitehttps://www.hyphensgroup.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| McPherson's Ltd | 180.33m | -3.19m | 61.14m | 876.00 | -- | 0.6247 | 29.27 | 0.339 | -0.0248 | -0.0248 | 1.40 | 0.7604 | 0.9907 | 2.09 | 5.72 | -- | -1.75 | 1.04 | -2.56 | 1.50 | 50.15 | 46.06 | -1.77 | 0.9152 | 0.9103 | 2.82 | 0.1822 | 409.37 | -1.79 | -0.0665 | -1,619.82 | -- | 0.3719 | -18.80 |
| Kingworld Medicines Group Ltd | 201.22m | 7.11m | 67.84m | 1.00k | 9.07 | 0.5875 | 4.45 | 0.3372 | 0.0695 | 0.0695 | 1.97 | 1.07 | 0.8294 | 7.89 | 13.47 | 1,160,811.00 | 4.74 | 4.07 | 8.57 | 8.00 | 26.02 | 29.72 | 5.71 | 5.59 | 1.02 | -- | 0.3363 | 41.83 | 12.63 | -0.0034 | 67.52 | -1.46 | 54.82 | 9.24 |
| Navamedic ASA | 64.56m | 480.94k | 77.60m | 10.00 | 161.42 | 2.75 | 39.10 | 1.20 | 0.2187 | 0.2187 | 29.61 | 12.84 | 1.13 | 3.39 | 6.24 | -- | 0.8409 | 0.0724 | 1.29 | 0.1177 | 38.88 | 38.33 | 0.7449 | 0.0704 | 0.5558 | 1.85 | 0.4069 | -- | 33.98 | 22.72 | -87.04 | 0.3123 | 59.60 | -- |
| Kim Forest Enterprise Co Ltd | 17.43m | -5.60m | 80.09m | -- | -- | 3.37 | -- | 4.60 | -2.85 | -2.85 | 8.89 | 11.29 | 0.4986 | 3.34 | 4.31 | -- | -16.02 | -0.8245 | -19.78 | -1.06 | 13.15 | 31.99 | -32.14 | -1.25 | 1.19 | -82.43 | 0.2664 | -- | -38.11 | 12.36 | -341.58 | -- | -8.51 | -- |
| Sinco Pharmaceuticals Holdings Ltd | 473.83m | 7.90m | 86.16m | 278.00 | 10.91 | 0.7354 | 7.90 | 0.1818 | 0.0225 | 0.0225 | 1.35 | 0.3331 | 1.53 | 22.60 | 5.73 | 9,852,459.00 | 2.56 | 6.48 | 6.55 | 20.22 | 12.73 | 14.79 | 1.67 | 3.86 | 1.08 | 28.20 | 0.2859 | 7.21 | 11.82 | 21.66 | -39.03 | -- | 123.63 | -- |
| Hyphens Pharma International Ltd | 170.60m | 8.57m | 91.21m | 440.00 | 10.65 | 1.45 | 8.02 | 0.5347 | 0.0277 | 0.0277 | 0.5513 | 0.2037 | 1.45 | 4.65 | 4.89 | 387,715.90 | 7.29 | 8.35 | 12.10 | 14.01 | 36.29 | 37.06 | 5.03 | 5.65 | 1.35 | -- | 0.0939 | 33.00 | 5.10 | 7.12 | -24.52 | 9.63 | -18.70 | 9.35 |
| Able View Global Inc | 201.26m | 12.75m | 92.20m | 98.00 | 7.31 | 6.05 | 7.06 | 0.4581 | 0.2229 | 0.2229 | 3.52 | 0.2695 | 2.72 | 6.20 | 8.37 | 1,520,406.00 | 17.80 | -- | 30.88 | -- | 24.84 | -- | 6.54 | -- | 1.99 | 7.90 | 0.2017 | -- | 2.58 | -- | 23.46 | -- | -- | -- |
| Harima-Kyowa Co., LTD. | 530.56m | 12.12m | 97.42m | 197.00 | 7.94 | 0.4628 | 7.76 | 0.1836 | 261.75 | 261.75 | 11,459.40 | 4,490.24 | 1.91 | 23.79 | 5.51 | -- | 4.36 | 4.39 | 5.70 | 5.87 | 11.57 | 11.73 | 2.28 | 2.23 | 2.22 | -- | 0.0131 | 17.15 | 2.37 | 5.01 | 1.10 | 3.25 | 34.30 | 3.44 |
| Natural Health Trends Corp. | 58.10m | 674.02k | 110.45m | 138.00 | 163.48 | 2.08 | 125.41 | 1.90 | 0.0434 | 0.0434 | 3.75 | 3.42 | 0.582 | 2.24 | -- | 311,695.70 | 0.6751 | -0.5398 | 0.9333 | -0.7099 | 74.30 | 74.06 | 1.16 | -0.9571 | 2.77 | -- | 0.00 | -- | -10.60 | -25.54 | 81.47 | -54.86 | -26.47 | 6.64 |
| Balaxi Pharmaceuticals Ltd | 42.54m | -847.21k | 116.89m | 51.00 | -- | -- | -- | 2.75 | -5.30 | -5.30 | 255.76 | -- | -- | -- | -- | 51,400,510.00 | -- | 31.86 | -- | 46.07 | 42.45 | 32.28 | -1.99 | 15.43 | -- | -- | -- | -- | 20.42 | -- | -3.56 | -- | 314.83 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Nikko Asset Management Asia Ltd.as of 31 Dec 2023 | 4.00m | 1.29% |
